Dr. Mark Applefeld, MD

Cardiovascular Disease Baltimore, MD Male
NPI: 1124060215
Total Payments
$7,276
2024 Payments
$50.91
Companies
32
Transactions
374
Medicare Patients
3,983
Medicare Billing
$132,250

Payment Breakdown by Category

Food & Beverage$6,972 (95.8%)
Education$278.37 (3.8%)
Consulting$25.57 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,972 366 95.8%
Education $278.37 7 3.8%
Consulting Fee $25.57 1 0.4%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $1,225 71 $0 (2022)
Amgen Inc. $868.73 39 $0 (2020)
Janssen Pharmaceuticals, Inc $571.99 42 $0 (2021)
Amarin Pharma Inc. $567.17 27 $0 (2021)
AstraZeneca Pharmaceuticals LP $527.36 31 $0 (2021)
SANOFI-AVENTIS U.S. LLC $438.19 23 $0 (2021)
Abbott Laboratories $427.91 13 $0 (2022)
Kowa Pharmaceuticals America, Inc. $352.81 16 $0 (2021)
Astellas Pharma US Inc $303.04 7 $0 (2019)
E.R. Squibb & Sons, L.L.C. $260.48 19 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $50.91 2 Cook Medical LLC ($50.91)
2023 $118.19 4 Cook Medical LLC ($73.05)
2022 $152.11 5 AtriCure, Inc. ($56.42)
2021 $1,453 70 Amarin Pharma Inc. ($272.20)
2020 $347.72 19 Novartis Pharmaceuticals Corporation ($124.37)
2019 $1,479 80 Novartis Pharmaceuticals Corporation ($336.89)
2018 $1,879 100 Amgen Inc. ($427.86)
2017 $1,796 94 Amgen Inc. ($292.45)

All Payment Transactions

374 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
05/23/2024 Cook Medical LLC ZENITH SPIRAL-Z (Device) Food and Beverage Cash or cash equivalent $13.06 General
Category: Aortic Intervention
02/29/2024 Cook Medical LLC ZENITH SPIRAL-Z (Device) Food and Beverage Cash or cash equivalent $37.85 General
Category: Aortic Intervention
10/09/2023 Cook Medical LLC ZENITH SPIRAL-Z (Device) Food and Beverage Cash or cash equivalent $28.20 General
Category: Aortic Intervention
05/22/2023 ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) Food and Beverage In-kind items and services $22.03 General
Category: CARDIOVASCULAR
03/29/2023 ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) Food and Beverage In-kind items and services $23.11 General
Category: CARDIOVASCULAR
03/14/2023 Cook Medical LLC ZENITH SPIRAL-Z (Device) Food and Beverage Cash or cash equivalent $44.85 General
Category: Aortic Intervention
08/28/2022 AtriCure, Inc. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) Food and Beverage In-kind items and services $24.67 General
Category: CARDIOVASCULAR
04/28/2022 Abbott Laboratories ASSURITY (Device) Food and Beverage In-kind items and services $45.51 General
Category: Cardiac Rhythm Management
03/21/2022 Cook Medical LLC ZENITH SPIRAL-Z (Device) Food and Beverage Cash or cash equivalent $26.83 General
Category: Aortic Intervention
03/14/2022 AtriCure, Inc. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) Food and Beverage In-kind items and services $31.75 General
Category: CARDIOVASCULAR
01/04/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $23.35 General
Category: CARDIOVASCULAR
12/06/2021 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $20.82 General
Category: CARDIOVASCULAR
11/17/2021 Kowa Pharmaceuticals America, Inc. Livalo (Drug) Food and Beverage Cash or cash equivalent $23.14 General
Category: Cardiovascular
10/25/2021 Kowa Pharmaceuticals America, Inc. Livalo (Drug) Food and Beverage Cash or cash equivalent $27.00 General
Category: Cardiovascular
10/14/2021 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $22.59 General
Category: Cardiovascular
10/14/2021 AstraZeneca Pharmaceuticals LP — Food and Beverage In-kind items and services $19.38 General
10/07/2021 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $2.67 General
Category: CARDIOVASCULAR
10/06/2021 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $13.30 General
Category: CARDIOVASCULAR
10/05/2021 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $32.44 General
Category: DIABETES
09/30/2021 Kowa Pharmaceuticals America, Inc. Livalo (Drug) Food and Beverage Cash or cash equivalent $31.24 General
Category: Cardiovascular
09/28/2021 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $21.39 General
Category: Cardiovascular
09/23/2021 Merck Sharp & Dohme Corporation VERQUVO (Drug) Food and Beverage In-kind items and services $19.65 General
Category: CARDIOVASCULAR
09/21/2021 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $22.93 General
Category: Cardiovascular
09/17/2021 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $17.41 General
Category: CARDIOVASCULAR
09/16/2021 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $31.90 General
Category: DIABETES
123…15»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 9 1,915 2,498 $290,826 $66,451
2020 12 2,068 2,697 $286,712 $65,800
Total Patients
3,983
Total Services
5,195
Medicare Billing
$132,250
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 307 463 $148,819 $33,545 22.5%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 1,070 1,461 $39,509 $10,034 25.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 57 75 $31,851 $6,706 21.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 35 36 $17,352 $4,293 24.7%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 79 90 $19,429 $3,896 20.1%
93016 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision Facility 2021 158 159 $11,295 $2,722 24.1%
93018 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report Facility 2021 157 158 $7,432 $1,815 24.4%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 14 14 $6,245 $1,462 23.4%
99203 New patient outpatient visit, total time 30-44 minutes Facility 2021 15 15 $4,083 $1,007 24.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 11 13 $3,845 $742.04 19.3%
93288 Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report Facility 2021 12 14 $966.00 $228.80 23.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 355 551 $140,986 $31,280 22.2%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 1,104 1,488 $41,658 $10,416 25.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 68 85 $30,165 $6,654 22.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 55 60 $21,708 $5,401 24.9%
93016 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision Facility 2020 162 166 $11,952 $2,988 25.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 72 82 $13,684 $2,796 20.4%
93018 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report Facility 2020 161 165 $7,920 $1,981 25.0%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 13 13 $5,473 $1,365 24.9%
99203 New patient office or other outpatient visit, typically 30 minutes Facility 2020 18 18 $4,446 $1,111 25.0%
93289 Evaluation of defibrillator including connection, recording and disconnection Facility 2020 11 18 $2,194 $485.70 22.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 12 12 $2,934 $458.05 15.6%
93280 Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report Facility 2020 12 12 $1,508 $333.53 22.1%
93227 Heart rhythm tracing, analysis, and interpretation of 48-hour ekg Facility 2020 13 13 $1,118 $294.89 26.4%
93288 Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report Facility 2020 12 14 $966.00 $234.90 24.3%

About Dr. Mark Applefeld, MD

Dr. Mark Applefeld, MD is a Cardiovascular Disease healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124060215.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Applefeld, MD has received a total of $7,276 in payments from pharmaceutical and medical device companies, with $50.91 received in 2024. These payments were reported across 374 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,972).

As a Medicare-enrolled provider, Applefeld has provided services to 3,983 Medicare beneficiaries, totaling 5,195 services with total Medicare billing of $132,250. Data is available for 2 years (2020–2021), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Other Specialties Interventional Cardiology
  • Location Baltimore, MD
  • Active Since 06/12/2006
  • Last Updated 02/21/2014
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1124060215

Products in Payments

  • ENTRESTO (Drug) $1,225
  • Corlanor (Drug) $730.59
  • XARELTO (Drug) $571.99
  • Vascepa (Drug) $567.17
  • BRILINTA (Drug) $465.04
  • Livalo (Drug) $352.81
  • PRALUENT (Drug) $347.32
  • ELIQUIS (Drug) $290.56
  • LifeVest (Device) $248.87
  • Agilis NxT EP Introducer (Device) $200.41
  • ZENITH SPIRAL-Z (Device) $150.79
  • Repatha (Biological) $122.87
  • JARDIANCE (Drug) $117.11
  • Edarbi (Drug) $109.96
  • EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $101.56
  • ZIO Patch (Device) $94.67
  • PRALUENT ALIROCUMAB INJECTION (Biological) $79.57
  • MULTAQ (Drug) $78.49
  • PRADAXA (Drug) $75.65
  • Lexiscan (Drug) $56.80

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Baltimore

Dr. Navin Kapur, M.d, M.D

Cardiovascular Disease — Payments: $1.8M

Cardiovascular Disease $1.8M

Sanjay Rajagopalan, Md, MD

Cardiovascular Disease — Payments: $572,017

Cardiovascular Disease $572,017

Dr. Michael Blaha, M.d., Mph, M.D., MPH

Cardiovascular Disease — Payments: $569,288

Cardiovascular Disease $569,288

Hugh Calkins, M.d, M.D

Cardiovascular Disease — Payments: $387,473

Cardiovascular Disease $387,473

Dr. Charles Cummings, M.d, M.D

Cardiovascular Disease — Payments: $337,057

Cardiovascular Disease $337,057

Dr. Charles Love, M.d, M.D

Cardiovascular Disease — Payments: $327,551

Cardiovascular Disease $327,551